Stay updated on Lumateperone in Schizophrenia Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page.

Latest updates to the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page
- Check3 days agoChange DetectedA government funding notice explaining potential delays and operating status was removed from the page. The removal does not affect the study data or how to navigate the page.SummaryDifference0.7%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedDifference0.8%

- Check32 days agoChange DetectedAdds a comprehensive study documentation section (status, design, outcome measures, participant flow, results, adverse events, quality control) with a return date, signaling ongoing research activity.SummaryDifference4%

- Check46 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference13%

- Check53 days agoChange DetectedResults have moved from no results posted to results submitted, with a new version tag v3.1.0 replacing v3.0.2.SummaryDifference0.8%

- Check67 days agoChange DetectedUpdated the page to revision v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed.SummaryDifference0.8%

Stay in the know with updates to Lumateperone in Schizophrenia Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page.